GMAB
Genmab A/S
NASDAQ · Healthcare · Biotechnology · DK
$33.60
−2.35%Leverage
- Debt / equity
- 0.89x
- Net debt / equity
- 0.63x
- Debt / assets
- 0.42x
- Debt / EBITDA
- 4.32x
- Net debt / EBITDA
- 3.09x
Liquidity & coverage
- Current ratio
- 2.46x
- Quick ratio
- 2.44x
- Cash ratio
- 1.32x
- Interest coverage
- 4.95x
- EBITDA / interest
- 4.53x
- Working capital
- $1.7B
Cash & dividend
- FCF / debt
- 0.16x
- Cash flow / debt
- 0.17x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026